Get Your Own Businessabc AI Visibility ID
Boost AI visibility, credibility, and discoverability
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMBA, which is in phase I clinical trial; BX3000, an NMBA reversal agent; and Dex-IN, a proprietary intranasal formulation of dexmedetomidine. The company was incorporated in 2019 and is based in Malvern, Pennsylvania.
Baudax Bio was founded in 1955 by Dr. Nancy Holtman. Dr. Holtman had a vision to create groundbreaking treatments for women’s health conditions. After painstaking research and development, Baudax Bio has earned a reputation for developing and manufacturing treatments with exceptional safety and efficacy.
At Baudax Bio, our mission is to develop and deliver innovative therapies that improve health outcomes and enhance the quality of life for women around the world.
Our vision is to become the world leader in women’s health innovation through creating treatments that provide the highest quality care to patients in need.
